Bellevue Group’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-50,853
Closed -$2.94M 171
2024
Q2
$2.94M Buy
50,853
+12,696
+33% +$733K 0.05% 106
2024
Q1
$1.27M Sell
38,157
-79,185
-67% -$2.64M 0.02% 116
2023
Q4
$9.52M Sell
117,342
-43,220
-27% -$3.51M 0.15% 87
2023
Q3
$26.2M Sell
160,562
-47,830
-23% -$7.81M 0.42% 67
2023
Q2
$68.4M Buy
208,392
+14,608
+8% +$4.79M 0.98% 31
2023
Q1
$53.5M Buy
193,784
+4,205
+2% +$1.16M 0.78% 46
2022
Q4
$73.4M Buy
189,579
+28,415
+18% +$11M 0.97% 32
2022
Q3
$38.5M Buy
161,164
+6,049
+4% +$1.45M 0.55% 54
2022
Q2
$34.6M Buy
155,115
+20,638
+15% +$4.6M 0.49% 60
2022
Q1
$91.6M Buy
134,477
+97,103
+260% +$66.1M 1.06% 32
2021
Q4
$25.8M Buy
37,374
+6,903
+23% +$4.77M 0.27% 94
2021
Q3
$22.6M Hold
30,471
0.23% 100
2021
Q2
$22.8M Buy
30,471
+13,423
+79% +$10.1M 0.22% 104
2021
Q1
$13.9M Buy
17,048
+4,401
+35% +$3.59M 0.15% 112
2020
Q4
$10.8M Buy
12,647
+7,319
+137% +$6.24M 0.12% 115
2020
Q3
$4M Buy
+5,328
New +$4M 0.06% 129